Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.

PubWeight™: 2.18‹?› | Rank: Top 2%

🔗 View Article (PMC 2725691)

Published in J Clin Microbiol on June 17, 2009

Authors

Mark W Pandori1, John Hackett, Brian Louie, Ana Vallari, Teri Dowling, Sally Liska, Jeffrey D Klausner

Author Affiliations

1: San Francisco Department of Public Health, CA 94102, USA. Mark_Pandori@sfdph.org

Articles citing this

Will gay and bisexually active men at high risk of infection use over-the-counter rapid HIV tests to screen sexual partners? J Sex Res (2012) 2.76

Evaluation of an HIV nucleic acid testing program with automated Internet and voicemail systems to deliver results. Ann Intern Med (2010) 2.69

Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis (2012) 1.78

Costs per Diagnosis of Acute HIV Infection in Community-based Screening Strategies: A Comparative Analysis of Four Screening Algorithms. Clin Infect Dis (2015) 1.23

Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. AIDS (2011) 1.16

Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men. J Clin Virol (2013) 1.14

Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One (2013) 1.07

ru2hot?: A public health education campaign for men who have sex with men to increase awareness of symptoms of acute HIV infection. Sex Transm Infect (2013) 1.05

Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays. J Clin Microbiol (2011) 1.03

Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population. PLoS One (2014) 0.98

Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm. AIDS (2013) 0.98

HIV surveillance in a large, community-based study: results from the pilot study of Project Accept (HIV Prevention Trials Network 043). BMC Infect Dis (2011) 0.97

HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men. J Acquir Immune Defic Syndr (2012) 0.90

Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection. J Clin Microbiol (2012) 0.89

Quarantine Plasma: Quo vadis? Transfus Med Hemother (2010) 0.87

Detection of HIV-1 p24 at Attomole Level by Ultrasensitive ELISA with Thio-NAD Cycling. PLoS One (2015) 0.82

Finding those at risk: acute HIV infection in Newark, NJ. J Clin Virol (2013) 0.81

Generation of a recombinant Gag virus-like-particle panel for the evaluation of p24 antigen detection by diagnostic HIV tests. PLoS One (2014) 0.79

Prolonged second diagnostic window for human immunodeficiency virus type 1 in a fourth-generation immunoassay: are alternative testing strategies required? J Clin Microbiol (2014) 0.79

Misdiagnosis of HIV infection during a South African community-based survey: implications for rapid HIV testing. J Int AIDS Soc (2017) 0.78

Brief Report: Health-Seeking Behavior and Symptoms Associated With Early HIV Infection: Results From a Population-Based Cohort in Southern Malawi. J Acquir Immune Defic Syndr (2015) 0.78

Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM. J Clin Virol (2016) 0.77

A portable paper-based microfluidic platform for multiplexed electrochemical detection of human immunodeficiency virus and hepatitis C virus antibodies in serum. Biomicrofluidics (2016) 0.76

Ultrasensitive detection of proteins and sugars at single-cell level. Commun Integr Biol (2016) 0.75

Acute infections, cost and time to reporting of HIV test results in three U.S. State Public Health Laboratories. J Infect (2016) 0.75

Performance of the Liaison XL Murex HIV Ab/Ag test on clinical samples representing current epidemic HIV variants. J Clin Microbiol (2014) 0.75

An urgent need for introduction of fourth-generation Ag-Ab based EIA for detection of HIV infection. Med J Armed Forces India (2014) 0.75

The characteristics of screening and confirmatory test results for HIV in Xi'an, China. PLoS One (2017) 0.75

A rapid ultrasound particle agglutination method for HIV antibody detection: Comparison with conventional rapid HIV tests. J Virol Methods (2017) 0.75

Articles cited by this

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS (2003) 11.66

Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30

Detection of acute infections during HIV testing in North Carolina. N Engl J Med (2005) 7.60

Amplified transmission of HIV-1: comparison of HIV-1 concentrations in semen and blood during acute and chronic infection. AIDS (2007) 3.72

Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS (2005) 3.40

Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis (2006) 2.44

Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays. J Clin Microbiol (1998) 2.25

Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr (2006) 2.15

Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Methods (2004) 1.82

Probability of HIV transmission during acute infection in Rakai, Uganda. AIDS Behav (2007) 1.76

Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J Acquir Immune Defic Syndr (2007) 1.71

Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J Virol Methods (2007) 1.65

Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: evaluation of HIV seroconversion sensitivity and subtype detection. J Clin Microbiol (2001) 1.45

Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J Clin Microbiol (2002) 1.44

Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra. J Clin Microbiol (2002) 1.42

Sensitivity of HIV-antibody assays determined by seroconversion panels. AIDS (1994) 1.37

Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals. J Clin Microbiol (2008) 1.26

Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay. J Virol Methods (1999) 1.11

Difficulties in diagnosing group o human immunodeficiency virus type 1 acute primary infection. J Clin Microbiol (2008) 1.04

Evidence for a diagnostic window in fourth generation assays for HIV. J Clin Virol (2001) 1.00

Combination assay detecting both human immunodeficiency virus (HIV) p24 antigen and anti-HIV antibodies opens a second diagnostic window. J Clin Microbiol (2005) 0.98

Relevance of a combined HIV antigen/antibody assay to detect early HIV infections in a low prevalence population: case reports. Clin Lab (2004) 0.96

Use of an acute seroconversion panel to evaluate a third-generation enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies relative to multiple other assays. J Clin Microbiol (2006) 0.94

Evaluation of a new fourth generation enzyme-linked immunosorbent assay, the LG HIV Ag-Ab Plus, with a combined HIV p24 antigen and anti-HIV-1/2/O screening test. J Virol Methods (2006) 0.93

Performance characteristics of recombinant enzyme immunoassay to detect antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 and to measure early antibody responses in seroconverting patients. J Clin Microbiol (1996) 0.89

Early detection of antibodies to human immunodeficiency virus 1 by a third-generation enzyme immunoassay. A comparative study with the results of second-generation immunoassays and western blot. Ann Biol Clin (Paris) (1994) 0.83

A new automated fourth-generation HIV screening assay with sensitive antigen detection module and high specificity. Methods Mol Biol (2005) 0.83

[Screening of HIV in blood banks. Evaluation of fourth generation kits]. Medicina (B Aires) (2003) 0.81

Evaluation of a new third-generation ELISA for the detection of HIV infection. Ann Clin Lab Sci (2006) 0.80

A new combined HIV p24 antigen and anti-HIV-1/2/O screening assay. Methods Mol Biol (2005) 0.80

Articles by these authors

Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health (2002) 6.01

Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr (2008) 5.05

Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA (2005) 4.32

Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS (2004) 4.17

Public health. Reassessing HIV prevention. Science (2008) 4.06

Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med (2004) 3.54

"Street medicine": Collaborating with a faith-based organization to screen at-risk youths for sexually transmitted diseases. Am J Public Health (2004) 3.53

The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns. J Virol (2013) 3.37

Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis (2005) 3.28

SEXINFO: a sexual health text messaging service for San Francisco youth. Am J Public Health (2008) 3.16

Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS (2006) 2.85

Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr (2010) 2.79

Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance. AIDS (2006) 2.72

Sildenafil use, sexual risk behavior, and risk for sexually transmitted diseases, including HIV infection. Am J Med (2005) 2.59

Male circumcision for protection against HIV infection in sub-Saharan Africa: the evidence in favour justifies the implementation now in progress. Glob Public Health (2015) 2.56

Syphilis and HIV infection: an update. Clin Infect Dis (2007) 2.55

Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis (2008) 2.33

Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007. PLoS One (2008) 2.32

Association between rates of HIV testing and elimination of written consents in San Francisco. JAMA (2007) 2.32

Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999-2001, USA. Am J Public Health (2002) 2.30

Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS (2005) 2.22

Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr (2006) 2.15

Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis (2006) 2.10

Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. Sex Transm Dis (2005) 2.08

Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men. Sex Transm Dis (2011) 2.03

California guidelines for expedited partner therapy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis (2008) 2.03

Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men. Clin Infect Dis (2009) 2.02

Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003. Clin Infect Dis (2005) 2.01

Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. J Clin Microbiol (2004) 2.01

A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS One (2010) 1.99

No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science (2011) 1.90

Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR. Nucleic Acids Res (2007) 1.82

Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Methods (2004) 1.82

The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother (2009) 1.80

Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis (2012) 1.78

Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J Clin Microbiol (2005) 1.75

Men who have sex with men and transgenders in Mumbai, India: an emerging risk group for STIs and HIV. Indian J Dermatol Venereol Leprol (2006) 1.69

HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005. J Acquir Immune Defic Syndr (2008) 1.68

Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin Infect Dis (2005) 1.64

Evaluation of self-collected glans and rectal swabs from men who have sex with men for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of nucleic acid amplification tests. J Clin Microbiol (2009) 1.61

Characterization of antibodies elicited by XMRV infection and development of immunoassays useful for epidemiologic studies. Retrovirology (2010) 1.57

Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science (2011) 1.56

The epidemiology of herpes simplex virus type 2 infection in low-income urban populations in coastal Peru. Sex Transm Dis (2005) 1.54

Chlamydia and gonorrhea screening in San Francisco high schools. Sex Transm Dis (2002) 1.53

Increased sensitivity of DNA amplification testing for the detection of pharyngeal gonorrhea in men who have sex with men. Clin Infect Dis (2001) 1.52

Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection. Mayo Clin Proc (2007) 1.52

Clients of female sex workers in Lima, Peru: a bridge population for sexually transmitted disease/HIV transmission? Sex Transm Dis (2004) 1.52

Enhanced molecular typing of treponema pallidum: geographical distribution of strain types and association with neurosyphilis. J Infect Dis (2010) 1.51

The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries. Sex Transm Dis (2011) 1.50

Reduction in unnecessary Chlamydia screening among older women at title X-funded family planning sites following a structural intervention--San Francisco, 2009. Sex Transm Dis (2011) 1.49

Cephalosporin resistance in Neisseria gonorrhoeae infections. JAMA (2013) 1.47

Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother (2009) 1.47

A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples. J Virol Methods (2007) 1.47

Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay. J Acquir Immune Defic Syndr (2009) 1.46

The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. J Acquir Immune Defic Syndr (2008) 1.46

Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. AIDS Care (2009) 1.45

Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa. J Int AIDS Soc (2011) 1.42

inSPOT: the first online STD partner notification system using electronic postcards. PLoS Med (2008) 1.42

Field-delivered therapy increases treatment for chlamydia and gonorrhea. Am J Public Health (2003) 1.41

Longer hospital stay is associated with higher rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan Africa. BMC Infect Dis (2014) 1.41

Internet-based health promotion and disease control in the 8 cities: successes, barriers, and future plans. Sex Transm Dis (2005) 1.41

The impact of STIs. MLO Med Lab Obs (2006) 1.40

Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis (2007) 1.40

Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). PLoS One (2013) 1.40

Acceptability of male circumcision among mothers with male children in Mysore, India. AIDS (2008) 1.39

Diagnostic tests for common STDs and HSV-2. MLO Med Lab Obs (2004) 1.39

Routine detection of acute HIV infection through RNA pooling: survey of current practice in the United States. Sex Transm Dis (2007) 1.36

A 'snip' in time: what is the best age to circumcise? BMC Pediatr (2012) 1.36

Effect of a brief video intervention on incident infection among patients attending sexually transmitted disease clinics. PLoS Med (2008) 1.35

In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer. PLoS One (2012) 1.33

Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. J Virol Methods (2006) 1.33

Partner notification for sexually transmitted diseases in Peru: knowledge, attitudes, and practices in a high-risk community. Sex Transm Dis (2007) 1.33

Prevalence of same-sex sexual behavior and associated characteristics among low-income urban males in Peru. PLoS One (2007) 1.31

Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses. J Virol Methods (2006) 1.31

Using social networks to reach Black MSM for HIV testing and linkage to care. AIDS Behav (2012) 1.30

Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays. J Virol Methods (2006) 1.30

Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health (2009) 1.29

High rates of sex with men among high-risk, heterosexually-identified men in low-income, coastal Peru. AIDS Behav (2007) 1.28

Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV. J Virol (2011) 1.28

New populations at high risk of HIV/STIs in low-income, urban coastal Peru. AIDS Behav (2007) 1.27

HIV partner notification outcomes for HIV-infected patients by duration of infection, San Francisco, 2004 to 2006. J Acquir Immune Defic Syndr (2007) 1.27

Assessment of rapid tests for detection of human immunodeficiency virus-specific antibodies in recently infected individuals. J Clin Microbiol (2008) 1.26

Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India. Vaccine (2009) 1.24

Identification of HIV type 1 group N infections in a husband and wife in Cameroon: viral genome sequences provide evidence for horizontal transmission. AIDS Res Hum Retroviruses (2006) 1.24

An opportunity for prevention: prevalence, incidence, and sexual risk for HIV among young Asian and Pacific Islander men who have sex with men, San Francisco. Sex Transm Dis (2004) 1.23

Online syphilis testing--confidential and convenient. Sex Transm Dis (2005) 1.23

Molecular characterization of 39 HIV isolates representing group M (subtypes A-G) and group O: sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res Hum Retroviruses (2003) 1.23

Sarcoidosis as a benign cause of lymphadenopathy in cancer patients. Am J Surg (2009) 1.22

Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs. J Acquir Immune Defic Syndr (2009) 1.22